Infections caused by antibiotic-resistant bacteria are increasingly prevalent and difficult to treat. A new study identifies the unique vulnerabilities of a class of antibiotic-resistant mutants at the genomic scale, giving new insights into drugs that can be used in combination with antibiotics to suppress resistance.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
CDC. Antibiotic Resistance Threats in the United States 2019 (US Department of Health and Human Services, CDC, 2019).
Baym, M., Stone, L. K. & Kishony, R. Science 351, aad3292 (2016).
Rasouly, A. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-021-00973-1 (2021).
Adams, R. A. et al. J. Antibiot. (Tokyo) https://doi.org/10.1038/s41429-021-00462-x (2021).
Cain, A. K. et al. Nat. Rev. Gen. 21, 526–540 (2020).
Boehme, C. C. et al. New Engl. J. Med. 363, 1005–1015 (2010).
MacLean, R. C. & San Millan, A. Science 365, 1082–1083 (2019).
The author is supported by the Intramural Research Program of the NIH, National Cancer Institute (NCI), Center for Cancer Research.
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Khare, A. Achilles’ heel of antibiotic resistance. Nat Microbiol 6, 1339–1340 (2021). https://doi.org/10.1038/s41564-021-00985-x